1-5 of 5
Authors: Daniel Y. C. Heng
Save search
Sort by
Journal Article

Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens Open Access

PDF
Eddy Saad and others
The Oncologist, Volume 29, Issue 8, August 2024, Pages 699–706, https://doi.org/10.1093/oncolo/oyae072
Published: 17 April 2024
Journal Article

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors Open Access

PDF
Igor Stukalin and others
The Oncologist, Volume 28, Issue 9, September 2023, Pages 812–822, https://doi.org/10.1093/oncolo/oyad073
Published: 03 April 2023
Journal Article

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials Open Access

PDF
J Connor Wells and others
The Oncologist, Volume 27, Issue 3, March 2022, Pages e286–e293, https://doi.org/10.1093/oncolo/oyac020
Published: 19 February 2022
Journal Article

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model Free

PDF
Guillermo de Velasco and others
The Oncologist, Volume 22, Issue 3, March 2017, Pages 286–292, https://doi.org/10.1634/theoncologist.2016-0078
Published: 20 February 2017
Journal Article

Impact of Body Composition on Clinical Outcomes in Metastatic Renal Cell Cancer Free

PDF
Patricia A. Tang and others
The Oncologist, Volume 16, Issue 11, November 2011, Pages 1484–1486, https://doi.org/10.1634/theoncologist.2011-0337
Published: 21 October 2011